Stock CALC CALCIMEDICA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases CalciMedica, Inc.

Equities

CALC

US38942Q2021

End-of-day quote Nasdaq
Other stock markets
 23:00:00 26/06/2024 BST 		5-day change 1st Jan Change
3.15 USD -32.40% Intraday chart for CalciMedica, Inc. -41.12% +10.14%
06-27 CalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora? in Acute Pancreatitis CI
05-13 CalciMedica, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
CalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora in Acute Pancreatitis
AQ
CalciMedica : CARPO Trial Topline Results presentation
PU
CalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)
PR
CalciMedica to Host Conference Call to Review Topline Data from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)
PR
CalciMedica Reports First Quarter 2024 Financial Results and Provides Clinical & Corporate Updates
PR
CalciMedica Announces Last Patient Enrolled in Phase 2b CARPO Trial of Auxora in Acute Pancreatitis
AQ
CalciMedica Announces Last Patient Enrolled in Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis
PR
CalciMedica : Material Event - Form 8-K
PU
CalciMedica Presents Data from Preclinical Studies of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference
PR
CalciMedica Announces Presentation of Data from a Preclinical Study of Auxora in Acute Kidney Injury at the 29th International AKI and CRRT Conference
AQ
CalciMedica Announces Presentation of Data from a Preclinical Study of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference
PR
CalciMedica Announces FDA Clearance of IND Application for Phase 2 Trial of Auxora for the Treatment of Severe Acute Kidney Injury
AQ
CalciMedica Announces FDA Clearance of IND Application for Phase 2 Trial of Auxora™ for the Treatment of Severe Acute Kidney Injury
PR
CalciMedica to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
PR
CalciMedica Announces Private Placement of up to Approximately $55 Million
PR
CalciMedica Announces Upcoming Presentations and Events in September
PR
CalciMedica to Host Acute Pancreatitis Clinical Experts Event on September 21, 2023
PR
CalciMedica : BUSINESS SECTION - Form 8-K
PU
CalciMedica Reports Second Quarter 2023 Financial Results and Provides Clinical & Corporate Updates
GL
CalciMedica Announces First Patient Enrolled in International Expansion of CARPO Trial of Auxora™ in Acute Pancreatitis (AP)
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CALC Stock
  4. News CalciMedica, Inc.
  5. Press Releases